Artivion (AORT) Stock Price, Quote, News & History | Benzinga

SPY770.49+0.19%QQQ721.26+0.51%BTC/USD83,393.54+0.55%DIA524.63+0.05%GLD378.50+0.23%TLT80.06−0.08%

Artivion Inc (AORT) Stock Price, Quote, News & History

AORTNYSE

Trade with Public

Trade with Public

$23.09

0.813.64%

Last update: Oct 20, 4:00 PM

$23.09

0.813.64%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$23.09

Volume / Avg.

105.00 / 632.28K

Day Range

- - -

52 Wk Range

19.16 - 48.25

Market Cap

$1.13B

P/E Ratio

-

Dividend Yield

-

Exchange

NYSE

RSI

51

Short Interest

8.92%

Days to Cover

5.53

Recent Artivion, Inc. News

Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval

Artivion secured FDA PMA approval for AMDS, removing IRB hurdles and expanding access for acute aortic dissection patients.

Vandana Singh

Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results

US stocks traded higher, Nasdaq gained 1.5%. Dow down 0.06%. IT shares up 2.1% while healthcare stocks fell 0.9%. Fluor shares dropped 12% due to weak earnings. Westrock Coffee, Innodata, and Nlight shares rose. Artivion, DXC, and Kodiak AI shares fell. Oil up 1.1%, gold up 0.6%. European and Asian markets closed lower. US nonfarm payrolls beat estimates.

Avi Kapoor

Nasdaq Jumps 200 Points; US Adds 115,000 Jobs In April

US stocks rise as Nasdaq gains over 200 points, with tech leading. Nonfarm payrolls beat expectations but unemployment rate remains unchanged. Oil down 0.3%, gold up 0.8%, European and Asian markets close lower.

Avi Kapoor

UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday

Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks also see gains in today's session.

Avi Kapoor

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

41.71M

Investing Cash Flow (TTM)

-175.03M

Financing Cash Flow (TTM)

157.60M

Free Cash Flow (TTM)

-9.16M

Capital Expenditure (TTM)

-50.87M

Net Change in Cash (TTM)

24.28M

Analyst Trends and Forecast

1

May

1

Jun

1

Jul

1

Aug

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.46B

PE Ratio (TTM)

-

PE Ratio (FWD)

34.72

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.40

PB Ratio (TTM)

2.53

Earnings Yield % (TTM)

-0.26%

Earnings Yield % (FWD)

2.88%

EV / EBITDA (TTM)

28.52

Price / EBITDA (TTM)

22.19

Price / Free Cash Flow (TTM)

-

Book Value / Share

$9.14

Company Debt

Total Debt

$363.42M

LT Debt

$363.42M

LT Debt Issuance (TTM)

$148.88M

LT Debt Repayment (TTM)

-$76.00K

Total Cash

$77.32M

Debt to Equity

0.92

Issuance of Debt (TTM)

$148.80M

Repayment of Debt (TTM)

-$3.21M